skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I have been fortunate to recently get positions through secondary offerings for TRP / PPL / ENG. In the short term are all enjoying a nice bounce. I am concerned that they total 7% of my portfolio. My advisor feels I am not overweight, but I have asked him which one we should sell as I feel with my energy positions I should only have about 4% focused in pipelines. Which of the three would you drop, or would you just trim back all three to my targeted 4%. Keep up the great work.
Read Answer Asked by Mike on March 23, 2016
Q: For a diversified portfolio, would you choose DFS or FNV for roughly a three year hold? Thank you again for your careful answers to members' questions.
Read Answer Asked by Elaine or Gerry on March 23, 2016
Q: I had sent you a question last week about accepting the offer to convert to the new series preferred shares and wonder if I misunderstood you now. I did call the discount broker and told them that I would tender my preferred shares to the new series as the deadline was March 15 and then on Friday I received another notice that I could get $20.00 per shares in Cdn funds or US funds equivalent to $20.00 CDN. I called back the discount broker and told them that I wanted to take the US funds but was told that I could not because I tendered to the new series. Would this be correct? Should have I not received both options at the same time? I am wondering if you meant that I should tender to the offer price and not to the new preferred share? Normally when I get a take over I sell into the market to avoid all the confusion that can happened. I know that I can still sell into the market and most likely will but just wanted you answer on this situation.Should I call the trust company handling this transaction to see what their answer is?

Thanks
Dolores

Read Answer Asked on March 23, 2016
Q: I would like to purchase an ETF in a high yield bond fund similar to XHY but in US$. What are my options and which one would you recommend?
Read Answer Asked by George on March 23, 2016
Q: Would appreciate your view on PBH's aquisition of C&C. Accretive to earnings, but how much does this increase leverage from a higher debt load? What would their new debt to equity rario be? What is your view on the convertable debenture? For an income portcolio, woild you but the stock or the convertable debenture? Is the debenture a relatively safe investment, or should this be viewed as more risky high yield debt?
Thanks, great service.
Read Answer Asked by Hans on March 23, 2016
Q: I hold JPM and INVN in my US portfolio. INVN has not done much and JPM seems to be too dependent on the Fed.
What is your opinion on these two stocks and would I be better off selling these two and buying GILD.
(also own BRK.B, CVS, INTC, IWO, QQQ, VIG in my US account)

Thanks
Read Answer Asked by Irshad on March 23, 2016
Q: Your thoughts on etsy please.would you buy this or suggest an other stock.
Also I am thinking of adding to SPB.TO ,you think this is a good idea?
Read Answer Asked by Josh on March 23, 2016
Q: Can you compare RNW with BEP.UN? Which one would be the most preferable choice for income with some growth potential within an
RRSP? Thank you . Joe
Read Answer Asked by Joseph on March 23, 2016
Q: In a question from Darren on living off dividends in retirement, your answer did not mention the punitive tax treatment of dividends with respect to OAS clawback. I would appreciate your comments on this. My understanding is that the preferential tax treatment of dividend income is that it is based on an dividend payments by companies on earnings after the company has paid tax on its net revenues and the favourable tax treatment to the individual investor is only to level the overall CRA tax take. Why then are seniors being hit double with tax.

I have benefited greatly from your expertise and the daily dialogue in the Q&A. Thank you.

Cyril
Read Answer Asked by Pat & Cyril on March 23, 2016
Q: Hi Peter and Staff,

If I bought a stock, and never added to the position, but later sold it to generate a tax loss, am I correct in assuming that the Adjusted Cost Base (ACB) and the Book Value are one and the same? My broker supplied only book values. (I'm assuming that CRA considers ACB and Book Value to be different when an investor continues to add to a position, either through trading, or when enrolled in a DRIP program.) Am I correct? Is this why some advisors recommend that in order to simplify your tax return, you shouldn't enroll in a DRIP in a non-registered account? Or is calculating ACB when you DRIP easier than these advisors suggest?

Thanks as always for the valued advice.
Read Answer Asked by Jerry on March 23, 2016
Q: Peter and team,

I have holdings largely in line with the balanced equity portfolio. I've been considering adding some US stocks like SBUX, APPL, etc., but I have a question. If one holds the BE portfolio, is there really a need to add more US/global names? It seems the names in the BE portfolio have well diversified earnings sources and do business all over the world. Are we really adding anything with the out-of-Canada stocks?

Thanks
Read Answer Asked by Marc on March 23, 2016
Q: Help! I'm not an analyst or an accountant and I'm trying to do the calculations for EV/DACF on my oil stocks. I have added preferred shares to my EV less working capital(just added this recently). DACF= CFO+financing costs + exploration expences. Income tax and interest expences are already included in CFO so I'm not sure if I should be adding them in again? Would it work just to add financing activities and investing activities to CFO to get DACF. My head is swirling but i am determined to get it right. Need your help badly. Thank you for your service.
Read Answer Asked by Cheryl on March 22, 2016
Q: hi experts; what are the chances of getting paid out when it comes due next year?thanks brian
Read Answer Asked by brian on March 22, 2016
Q: Dear Team,
how would you rate these two biotech stocks? Trillium, having received financing, is now considered a 'strong buy'.
Thank you for your input!
Read Answer Asked by Sigrid on March 22, 2016
Q: Hi, I've read your bullish comments on a stock I've owned for years, PBH. If you look at a chart of PBH, it recently seems to be parabolic, which is usually a very bad sign for a stocks future.

Comments?
Read Answer Asked by Graeme on March 22, 2016
Q: Would like your view on pli after today's news,
sounds promising. Expensive here?
Thanks
Read Answer Asked by howard on March 22, 2016
Q: Your rating on this stock puzzles'me at a b+ the stock is range bound and illiquid when one gets in very difficult and expensive .RPI.un is rated at a C+ and has much the same problems with liquidity but much more growth and just increased its dividend .I hold both these stocks but the latter is a far better performer with a whole letter grade lower by your system
Your rating metrics confuse me .
Regards Stan
Read Answer Asked by Stan on March 22, 2016
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!